CLBT
Cellebrite DI
11.10$
-1.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +13.4% | +26.3% | +9.9% | +20.1% | +23.4% | +18.6% | |
| – | +5.7% | +12.3% | +19.2% | +4.9% | +17.6% | +20.1% | |
| – | +15.4% | +29.7% | +8.0% | +23.6% | +24.5% | +18.3% | |
| – | +16.8% | +20.5% | +23.0% | +4.7% | +16.6% | +15.7% | |
| – | +4.3% | +60.5% | -14.8% | +6.3% | +17.2% | +28.4% | |
| – | +7.5% | +28.4% | +15.3% | +9.0% | +18.0% | +18.6% | |
| – | – | +49.9% | -92.4% | +3,083.6% | +71.2% | +16.8% | |
| – | +304.3% | -89.2% | -2.6% | -5.4% | +247,956.7% | -99.9% | |
| – | +705.4% | +622.2% | +46.7% | -162.6% | – | – | |
| – | +70.6% | +94.2% | -100.4% | – | +26.8% | +75.9% | |
| – | – | +1,135.0% | +69.2% | -167.1% | – | – | |
| – | +207.2% | +417.9% | +45.4% | -150.3% | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.